immunodiagnosticsystems
0
immunodiagnosticsystems
0
  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    Hypertension
    CKD-MBD
    Growth
    Cartilage Markers
    Fertility
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • Investor Relations
  • Contact
immunodiagnosticsystems
+44 (0)191 5190660
0

Quotes

  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    Hypertension
    CKD-MBD
    Growth
    Cartilage Markers
    Fertility
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • Investor Relations
  • Contact

Month: June 2011

  • All News
  • Company News
  • Event News
  • Industry News
  • Product News
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 MARCH 2011

Preliminary Results for the Year Ended 31 March 2011

Immunodiagnostic Systems Holdings plc (AIM: IDH), a leading producer of diagnostic testing kits for the clinical and research markets, announces its preliminary results for the year ended 31 March 2011. IDS operates in the in-vitro diagnostics (“IVD”) market. The Company designs, manufactures and sells immunoassay kits which are used to measure or detect particular substances […]

FDA CLEARANCE FOR TWO NEW AUTOMATED ASSAYS

FDA Clearance for Two New Automated Assays

Immunodiagnostic Systems Holdings plc, a leading producer of diagnostic testing kits for the clinical and research markets, announces that clearance has been received from the US Food and Drug Administration (FDA) for the Company’s IGFBP-3 and CTX-I controls, enabling the related automated assays to be sold in the USA. Download Announcement

  • About Us
  • Products
  • Instrumentation
  • Clinical Areas
  • Research Areas
  • Investor Relations
  • Contact
  • Disclaimer

Sign up for our Newsletter

Connect with us
Connect with us
Connect with us
  • Careers
  • News & Events
  • Sitemap
  • Cookie Policy
  • Terms of Use Policy
  • Privacy Policy
  • Acceptable Use Policy
IDS PLC © 2017 Immunodiagnostic Systems. All Rights Reserved. IDS is a listed company, traded on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. Please note our sites uses cookies for content personalisation, please review our cookie policy for further information.

Sign up for our Newsletter

To receive our Newsletter Document Name, please provide us with your following details:

To receive our Newsletter, please provide us with your following details:

Close cookie popup

This website uses cookies: By continuing to browse this site you accept this policy.